Skip to main content
EYENational Vision Holdings, Inc.Sell6.0·$15.46
SellHigh Confidence
Investment thesis

National Vision offers a compelling value setup — a PEG of 0.14 and a forward multiple of 15.2x against a recent earnings track record featuring 46% average upside surprise — but is weighed down by a confirmed technical downtrend and 20% short interest. The risk/reward geometry of roughly 42% upside against 7% downside at nearly 6-to-1 creates an asymmetric opportunity if business momentum can overcome the bearish technical and sentiment overhang.

Thesis pillars

  • Strong Recent Earnings Execution→Stable
  • Cash Conversion Quality Gap→Stable
  • Compelling Valuation Very Low Peg↑Improving
  • +2 more pillars — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Mar 4, 2026

Full reasoning →

Open full analysis

National Vision Holdings, Inc. (EYE) Stock Analysis

Inst Constrain edge

SellVALUE-TRAP 1/5GrowthShortHigh Confidence

Consumer Cyclical · Specialty Retail

Earnings in 5 days (2026-11-04). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $15.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5.

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses,... Read more

$15.46+54.8% A.UpsideScore 6.0/10#7 of 23 Specialty Retail
QualityF-score8 / 9FCF yield3.98%
Stop $14.47Analyst target $23.93(−13% haircut)A.R:R 5.1:1
Analyst consensus$27.50+77.9%10 analysts
$23.93Analyst target
$15.46price
$27.50mean
$35

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $15.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.0/10, high confidence.

Passes 6/9 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and death cross (50MA < 200MA) and earnings proximity 5d<=7d. Suitability: speculative.

10-K grounded · weekly refresh

About National Vision Holdings, Inc.

About National Vision Holdings, Inc.

National Vision Holdings operated 1,250 retail optical stores across four brands at fiscal year-end January 3, 2026, with America's Best at 1,057 locations forming the core owned brand and Eyeglass World at 122 locations as the secondary format. Managed care insurance billing represented 42% of revenues from continuing operations in 2025, and omni-channel plus e-commerce platforms contributed approximately 7% of net revenue. The company opened 33 new stores in fiscal 2025 and targets 30 to 35 openings in fiscal 2026, with plans to reaccelerate to roughly 60 openings per year beginning 2028 for a total of approximately 240 new stores through 2030.

National Vision earns revenue through direct retail sales of frames and lenses, contact lens sales, and eye exam services provided by employed or contracted optometrists. The Eyecare Club subscription program — with approximately 1.3 million active members at January 3, 2026 — offers two eye exams per year plus a 10% discount for a one-time fixed multi-year fee, driving repeat traffic and contact lens refills. Supply is concentrated: EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses to National Vision under an agreement that runs through May 2028, while CooperVision manufactures the company's private label contact lens brands (Sofmed and Natural Eyes HydraWear). New store economics target a cash investment of $0.4 million to $0.6 million per location, with fifth-year sales of $1.5 million to $1.7 million and capital payback in three to five years. Competition spans independent optical retailers (roughly half the industry), mass merchants, warehouse clubs, specialty chains, and online contact lens sellers.

Show full overview

National Vision's managed care exposure at 42% of continuing operations revenues creates a dependency on vision insurance network admissions. The 10-K acknowledges that competition in managed care is based on price and network density and that the company may face heightened challenges to be admitted or to maintain status in managed care provider networks. Separately, the EssilorLuxottica sole-supply lens agreement expires in May 2028, creating a renegotiation event that could affect lens cost structure if renewal terms shift — a risk that compounds the managed care exposure since lens margin is a key driver of the value proposition to insurance-paying customers.

See also: Consumer Cyclical · Specialty Retail

From National Vision Holdings, Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Nov 4, 20265d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Positive insider activity
Risks
V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3)
Sector modifier (Consumer Cyclical): -1.5
Earnings in 5 days (event risk)

Key Metrics

P/E (TTM)24.9
P/E (Fwd)12.8
Mkt Cap$1.2B
EV/EBITDA10.2
Profit Mgn2.5%
ROE5.8%
Rev Growth2.5%
Beta0.98
DividendNone
Rating analysts16

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.01bullish
IV78%elevated
Max Pain$15-3.0% vs spot

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
1.0
Macd
1.9
Vol Acceleration
2.9
Rsi
4.5
Volume
10.0
Volume distribution (falling OBV)Below 200-MA, MA slope -7.1%/30d — confirmed downtrendVolume surge (2.1x avg) on selloff
GatesMomentum 3.6<4.5Death cross (50MA < 200MA)EARNINGS PROXIMITY 5d<=7dA.R:R 5.1 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Speculative
RSI
40 · Neutral
↓ 20D MA↓ 50D MA↓ 200D MADEATH CROSSSupport $14.92Resistance $18.87

Price Targets

$14
$24
A.Upside+54.8%
A.R:R5.1:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! momentum at 3.6 (below the engine's 4.5 threshold)
! Death cross — 50-day MA below 200-day MA
! EARNINGS_PROXIMITY:5d<=7d

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-11-04 (5d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is EYE stock a buy right now?

Sell if holding. Momentum 3.6/10 is below the 5.0 floor at $15.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $14.47. Score 6.0/10, high confidence.

What is the EYE stock price target?

Analyst target: $23.93 (+54.8% upside). Prior stop was $14.47. Stop-loss: $14.47.

What are the risks of investing in EYE?

V7 low-quality RISK_OFF penalty: -0.5 (Q=4.3); Sector modifier (Consumer Cyclical): -1.5; Earnings in 5 days (event risk).

Is EYE overvalued or undervalued?

National Vision Holdings, Inc. trades at a P/E of 24.9 (forward 12.8). TrendMatrix value score: 8.3/10. Verdict: Sell.

What do analysts say about EYE?

16 analysts cover EYE with a consensus score of 4.1/5. Average price target: $28.

What does National Vision Holdings, Inc. do?National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations),...

National Vision Holdings operates 1,250 retail optical stores across four brands — America's Best (1,057 locations), Eyeglass World (122 locations), and two Vista Optical host brands — throughout the United States. The company sells eye exams, eyeglasses, and contact lenses, with managed care insurance billing representing 42% of revenues from continuing operations in 2025. EssilorLuxottica holds the sole and exclusive right to supply certain eyeglass lenses under a contract running through May 2028.

Related stocks: BWMX (Betterware de Mexico, S.A.P.I. ) · MUSA (Murphy USA Inc.) · BBWI (Bath & Body Works, Inc.) · BOBS (Bob's Discount Furniture, Inc.) · SBH (Sally Beauty Holdings, Inc. (Na)
Home › Stocks › EYE

Latest news

Latest News

Investing.com197d ago
TradingView169d agoEarnings
Seeking Alpha169d agoEarnings
Moomoo169d ago
MSN169d ago
Yahoo Finance169d agoEarnings
GuruFocus169d agoEarnings
Investing.com169d agoEarnings
Marketscreener.com169d agoEarnings
Marietta Daily Journal169d agoEarnings
The Rome News-Tribune169d agoEarnings
10TV169d agoEarnings
KING5.com169d agoEarnings
KTVB169d agoEarnings
WKYC169d agoEarnings
Investing.com Canada78d ago
Marketscreener.com78d agoEarnings
Quiver Quantitative78d agoEarnings
TradingKey78d ago
The Rome News-Tribune78d agoEarnings
Loading more...